You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence
Discover Care Believe - boy on pier 

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

What do you #DiscoverCareBelieve? 

Multiple types of resistance to new lung cancer drug identified

May 04, 2015

After identifying three different types of resistance to a promising investigational lung cancer drug, a team of researchers led by Dana-Farber Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead of tumors’ constant and varied molecular shape-shifting.

patient and doctor 

New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

New targeted drug promising treatment option in resistant EGFR-positive lung cancers
April 29, 2015

A study led by Pasi Jänne, MD, PhD, found that an experimental drug targeted to the resistance mutation is highly active in patients with EGFR-positive non-small cell lung cancer (NSCLC) when the disease progressed during treatment with front-line inhibitor drugs.

Dana-Farber researcher awarded prestigious European scientific prize
April 24, 2015

Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium's most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders.

Minor gene mutations can produce extensive disruption of protein interactions, study finds
April 23, 2015

In a new study, researchers at Dana-Farber Cancer Institute show that disruptions to the activity of cell proteins can reveal which genetic mutations lead to disease and which are mere bystanders.

Eating on Chemo: Tips to Overcome Taste and Weight Challenges (USNews)

April 27, 2015

Dana-Farber nutritionist Stacy Kennedy, MPH, discussed the importance of maintaining good nutrition for cancer patients.

New targeted drug promising treatment option in resistant EGFR-positive lung cancers (USNews)
May 01, 2015

Dr. Pasi Janne led a study showing a new targeted drug as a promising treatment for advanced lung cancers.

Children with advanced cancer experience high symptom distress (Oncology Nurse Advisor)
April 29, 2015

Dr. Joanne Wolfe led a study that examined symptom distress in children living with advanced cancer, and found that a majority experience high symptom distress.

My First Male Mammogram (
April 27, 2015

Dr. Judy Garber discussed breast cancer among men and the lack of awareness despite a surge in news surrounding the BRCA gene.

Many Breast Cancer Patients Still Opt for Mastectomy Over Lump Removal (WBZ-TV)
April 24, 2015

Dr. Mehra Golshan led a study that shows many patients are opting for a mastectomy despite the high success rates a lumpectomy can offer.

Bristol-Myers Drug Combination Shows Promise Against Melanoma (Wall Street Journal)
April 21, 2015

Dr. F. Stephen Hodi co-led a study that found combining two drugs that unleash the immune system to attack cancer was significantly more effective in stifling tumors in melanoma patients than using just one of the treatments alone.

E-cigarette battle heats up (Harvard Gazette)
April 17, 2015

K. "Vish" Viswanath, PhD was a panelist for a discussion titled "Can E-cigarette Regulation Protect the Public’s Health? Making Sense of the Science."

Lymphoma Support Group

May 05, 2015

12:30 PM - 1:30 PM

Smith Building, Room 335

Please join us in a monthly support group for people diagnosed with lymphoma and their caregivers. This is an opportunity to meet others, share experiences, comfort, and support.


Facilitator: Kelly Drummond, MSW, LCSW


Registration required: Please contact Kelly Drummond at 617-632-5963 or
Please note: a minimum of 5 participants per session are needed for this group to meet
Parking validated in the DFCI Yawkey Garage
*Call-in options are available if you cannot attend in-person


Tai Chi for Optimal Health

May 05, 2015

3:00 PM - 4:30 PM

Smith Room, 330, Stoneman Patient Services Suite

An internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. Please register at 617-632-3322. more

Sunset Qigong

May 05, 2015

4:30 PM - 6:00 PM

Smith Room 330, Stoneman Patient Services Suite

Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322. more

  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    Quick access: Appointments as soon as the next day for new adult patients

    For children:

    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button 
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2014-2015 logo    U.S. News Best Children's Hospitals Cancer 2014-2015 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight 

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now